Han G, Gottlieb A, Armstrong A, Strober B, Soung J, Herr H, Davis L, Lebwohl M. Bimekizumab Efficacy through Year 1 in Patients with Moderate to Severe Plaque Psoriasis Who Had Not Achieved a PASI 90 Response by Week 16: A Pooled Analysis from Four Phase 3/3B Trials. J of Skin [Internet]. 2024Mar.18 [cited 2024Jul.22];8(2):s369. Available from: https://jofskin.org/index.php/skin/article/view/2701